Non-comparative Trial Following Participants Implanted Bilaterally With Mini WELL Toric Ready Intraocular Lens for 6 Months After the Second Eye Implant (FUSION)

Inclusion Criteria: * Eighteen years of age or older at the time of surgery and diagnosed with bilateral cataracts; * Planned bilateral cataract removal by phacoemulsification; * Preoperative total corneal astigmatism of 0.89 - 2.91 D, measured by corneal topography in both operative eyes; * IOL power and cylinder requirement calculated by the specific web-based Mini Toric Calculator within the following range: * Cylinder of: 1.50 D to 4.00 D * Spherical Equivalent of: 18.00 to 28.00 D * Willing and able to complete all required postoperative visits; * Clear intraocular media other than cataract; * Available for second-eye surgery within 2 weeks of the initial operation; * Potential postoperative visual acuity of 0.3 logMAR in both eyes; * Able to comprehend and sign a statement of informed consent consistent with local regulation for research in human subjects. Exclusion Criteria: * Irregular / asymmetric astigmatism; * Significant irregular corneal aberration as demonstrated by corneal topography; * Keratopathy / Kerectasia - any corneal abnormality, other than regular corneal astigmatism, including, but not limited to the following: keratoconus, keratoglobus, keratolysis, keratomalacia, keratomicosis and corneal plana; * Any inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjuntivitis and keratouveitis; * Subjects with diagnosed degenerative visual disorder (e.g. macular degeneration or other retinal disorders) that are predicted (by subjective assessment of the retina) to cause future acuity losses to a level worse than 0.3 logMAR; * Subjects who may have reasonably been expected to require a secondary surgical intervention at any time during the study (other than Nd:YAG capsulotomy); * Subjects in whom the intraocular lens might interfere with the ability to observe, diagnose or treat posterior segment conditions; * Previous corneal refractive surgery; * Other planned ocular surgery procedures, including, but not limited to LASIK, astigmatic keratotomy, retinal laser treatment and limbal relaxing incisions, for the duration of the study; * Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens, including but not limited to the following: pseudo-exfoliation syndrome, chronic uveitis, Marfan's Syndrome; * Absence of adequate capsular support for the implant of the intraocular lens in the capsular bag; * Absence of adequate support for the lens from the posterior chamber or the zonule; * Pupil abnormalities, including but not limited to the following: non-reactive, tonic pupils that do not dilatate under mesopic/scotopic conditions, abnormally shaped pupils or abnormally positioned pupils; * Amblyopia; * Clinically severe corneal dystrophy (e.g. epithelial, stromal, or endothelial dystrophy); * Proliferative diabetic retinopathy; * Microphthalmos; * Suspected microbial infection; * Previous retinal detachment; * Previous corneal transplant; * Optic nerve atrophy; * Extremely shallow anterior chamber, not due to swollen cataract; * Recurrent severe anterior or posterior segment inflammation of unknown aetiology (e.g. chronic uveitis); * Iris neovascularization; * Glaucoma (uncontrolled or controlled with medication); * Aniridia or iris atrophy; * Severe dry eye; * Use of any systemic or topical drug known to interfere with visual performance; * Subjects with any systemic disease that could increase operative risk or confound the outcomes (e.g. uncontrolled diabetes); * Use of contact lens within the last 30 days before the preoperative visit; * Vulnerable subjects (children \<18 years, people in guardianship or trusteeship or inability to give an informed consent); * Pregnant or lactating or planning a pregnancy at the time of enrolment; * Subjects with psychiatric disorders that could confound the outcomes; * Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days. Intra-operative exclusion criteria: * Irregularity and decentration of capsulorhexis; * Other ocular surgery procedures, including, but not limited to LASIK, astigmatic keratotomy, retinal laser treatment and limbal relaxing incisions, for the duration of the study; * Significant vitreous loss; * Significant anterior chamber hyphema; * Uncontrollable intraocular pressure (IOP); * Zonular or capsular rupture; * Ciliary sulcus, Bag-sulcus, sulcus-sulcus or unknown placement of the haptics.